| 摘要 |
FIELD: medicine.SUBSTANCE: present group of inventions refers to medicine, namely therapy and neurology, and concerns a melatonin agonist therapy. As the above melatonin agonist, (lR-Trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide is administered in effective doses that provides treating or preventing disruption of circadian rhythm or sleep disturbance.EFFECT: invention provides treating or preventing disruption of circadian rhythm or sleep disturbance.9 cl, 2 ex, 4 tbl |
